Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury.

F. Chamoun, M. Burne, M. O'Donnell, Hamid Rabb

Research output: Contribution to journalArticle

Abstract

Research findings are unveiling the potential role of leukocytes and leukocyte adhesion molecules such as selectins in ischemia-reperfusion injury (IRI). "Anti-adhesion" therapy using selectin blocking agents may represent a new approach to treatment of the many diverse clinical disorders in which ischemia-reperfusion occurs, including transplantation, reperfusion after thrombotic events and shock. In this paper we review the pathophysiology of IRI, the different types of selectins and selectin ligands, the clinical implications of selectin blockade in different organs with IRI, and new insights into mechanism of action.

Original languageEnglish (US)
JournalFrontiers in bioscience : a journal and virtual library
Volume5
StatePublished - 2000
Externally publishedYes

Fingerprint

Selectins
Reperfusion Injury
Ligands
Reperfusion
Cell Adhesion Molecules
Shock
Leukocytes
Adhesion
Ischemia
Transplantation
Research

Cite this

Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury. / Chamoun, F.; Burne, M.; O'Donnell, M.; Rabb, Hamid.

In: Frontiers in bioscience : a journal and virtual library, Vol. 5, 2000.

Research output: Contribution to journalArticle

@article{f939b5f950c24705b4052883cde35dc7,
title = "Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury.",
abstract = "Research findings are unveiling the potential role of leukocytes and leukocyte adhesion molecules such as selectins in ischemia-reperfusion injury (IRI). {"}Anti-adhesion{"} therapy using selectin blocking agents may represent a new approach to treatment of the many diverse clinical disorders in which ischemia-reperfusion occurs, including transplantation, reperfusion after thrombotic events and shock. In this paper we review the pathophysiology of IRI, the different types of selectins and selectin ligands, the clinical implications of selectin blockade in different organs with IRI, and new insights into mechanism of action.",
author = "F. Chamoun and M. Burne and M. O'Donnell and Hamid Rabb",
year = "2000",
language = "English (US)",
volume = "5",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",

}

TY - JOUR

T1 - Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury.

AU - Chamoun, F.

AU - Burne, M.

AU - O'Donnell, M.

AU - Rabb, Hamid

PY - 2000

Y1 - 2000

N2 - Research findings are unveiling the potential role of leukocytes and leukocyte adhesion molecules such as selectins in ischemia-reperfusion injury (IRI). "Anti-adhesion" therapy using selectin blocking agents may represent a new approach to treatment of the many diverse clinical disorders in which ischemia-reperfusion occurs, including transplantation, reperfusion after thrombotic events and shock. In this paper we review the pathophysiology of IRI, the different types of selectins and selectin ligands, the clinical implications of selectin blockade in different organs with IRI, and new insights into mechanism of action.

AB - Research findings are unveiling the potential role of leukocytes and leukocyte adhesion molecules such as selectins in ischemia-reperfusion injury (IRI). "Anti-adhesion" therapy using selectin blocking agents may represent a new approach to treatment of the many diverse clinical disorders in which ischemia-reperfusion occurs, including transplantation, reperfusion after thrombotic events and shock. In this paper we review the pathophysiology of IRI, the different types of selectins and selectin ligands, the clinical implications of selectin blockade in different organs with IRI, and new insights into mechanism of action.

UR - http://www.scopus.com/inward/record.url?scp=0034321532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034321532&partnerID=8YFLogxK

M3 - Article

C2 - 11056080

AN - SCOPUS:0034321532

VL - 5

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

ER -